TSHA

Taysha Gene Therapies (TSHA)

Taysha Gene Therapies Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:TSHA

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/15	05:18	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TSHA	Taysha Gene Therapies Inc
2024/05/15	05:12	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:TSHA	Taysha Gene Therapies Inc
2024/05/15	05:01	GlobeNewswire Inc.	Taysha Gene Therapies Reports First Quarter 2024 Financial Results and Provides Corporate Update	NASDAQ:TSHA	Taysha Gene Therapies Inc
2024/05/08	05:05	GlobeNewswire Inc.	Taysha Gene Therapies to Release First Quarter 2024 Financial Results and Host Conference Call and Webcast on May 14	NASDAQ:TSHA	Taysha Gene Therapies Inc
2024/05/04	05:05	GlobeNewswire Inc.	Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:TSHA	Taysha Gene Therapies Inc
2024/05/02	21:00	GlobeNewswire Inc.	Taysha Gene Therapies Announces Regenerative Medicine Advanced Therapy (RMAT) Designation Granted by U.S. FDA for TSHA-102 in Rett Syndrome	NASDAQ:TSHA	Taysha Gene Therapies Inc
2024/04/05	21:00	GlobeNewswire Inc.	Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:TSHA	Taysha Gene Therapies Inc
2024/03/21	02:30	AllPennyStocks.com	Another Biotech Steals The Show Following Major Clinical Data Release	NASDAQ:TSHA	Taysha Gene Therapies Inc
2024/03/20	05:01	GlobeNewswire Inc.	Taysha Gene Therapies Reports Full Year 2023 Financial Results and Provides Corporate and Clinical Updates	NASDAQ:TSHA	Taysha Gene Therapies Inc
2024/03/19	20:27	IH Market News	US Index Futures Decline Ahead of Federal Reserve Meeting, Oil Prices Retreat	NASDAQ:TSHA	Taysha Gene Therapies Inc
2024/03/15	05:26	GlobeNewswire Inc.	Taysha Gene Therapies to Release Full-Year 2023 Financial Results, Provide Corporate and Clinical Updates and Host Conference Call on March 19	NASDAQ:TSHA	Taysha Gene Therapies Inc
2024/03/02	07:08	GlobeNewswire Inc.	Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:TSHA	Taysha Gene Therapies Inc
2024/02/29	22:00	GlobeNewswire Inc.	Taysha Gene Therapies Announces Updates to TSHA-102 Clinical Program in Rett Syndrome	NASDAQ:TSHA	Taysha Gene Therapies Inc
2024/02/16	06:01	GlobeNewswire Inc.	Taysha Gene Therapies Provides Update on Deprioritized Pipeline Programs	NASDAQ:TSHA	Taysha Gene Therapies Inc
2024/02/10	06:24	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:TSHA	Taysha Gene Therapies Inc
2024/02/02	22:00	GlobeNewswire Inc.	Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:TSHA	Taysha Gene Therapies Inc
2024/01/22	22:00	GlobeNewswire Inc.	Taysha Gene Therapies Announces Poster Presentation on TSHA-102 in Rett Syndrome at Upcoming British Paediatric Neurology Association 2024 Annual Conference	NASDAQ:TSHA	Taysha Gene Therapies Inc
2024/01/10	22:06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TSHA	Taysha Gene Therapies Inc
2024/01/10	22:00	GlobeNewswire Inc.	Taysha Gene Therapies Announces First Pediatric Patient Dosed with TSHA-102 in REVEAL Phase 1/2 Pediatric Trial in Rett Syndrome	NASDAQ:TSHA	Taysha Gene Therapies Inc
2024/01/05	22:00	GlobeNewswire Inc.	Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:TSHA	Taysha Gene Therapies Inc
2023/12/21	06:21	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TSHA	Taysha Gene Therapies Inc
2023/12/21	06:20	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:TSHA	Taysha Gene Therapies Inc
2023/12/19	21:30	PR Newswire (US)	Trinity Capital Inc. Provides $40 Million Term Loan to Taysha Gene Therapies	NASDAQ:TSHA	Taysha Gene Therapies Inc
2023/11/29	22:00	GlobeNewswire Inc.	Taysha Gene Therapies Announces Expanded Eligibility in REVEAL Phase 1/2 Adult Trial to Include Adolescent Rett Syndrome Patients	NASDAQ:TSHA	Taysha Gene Therapies Inc
2023/11/16	06:29	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TSHA	Taysha Gene Therapies Inc
2023/11/15	06:47	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TSHA	Taysha Gene Therapies Inc
2023/11/15	06:08	GlobeNewswire Inc.	Taysha Gene Therapies Reports Third Quarter 2023 Financial Results and Provides Corporate and Clinical Updates	NASDAQ:TSHA	Taysha Gene Therapies Inc
2023/11/07	22:00	GlobeNewswire Inc.	Taysha Gene Therapies to Release Third Quarter 2023 Financial Results and Host Conference Call and Webcast on November 14	NASDAQ:TSHA	Taysha Gene Therapies Inc
2023/11/04	05:41	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TSHA	Taysha Gene Therapies Inc
2023/11/04	05:40	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:TSHA	Taysha Gene Therapies Inc